Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
The New England Journal of Medicine|July 14, 2016
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S Davids, Haesook T Kim, Pavan Bachireddy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2014
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiationEdward A Copelan, Belinda R Avalos, Kwang Woo Ahn, et al.
Blood Advances|November 7, 2018
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemiaSaurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor LymphomaAlex F Herrera, Scott J Rodig, Joo Y Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.
Blood Advances|October 2, 2020
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDSVikas Gupta, Soyoung Kim, Zhen-Huan Hu, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
The New England Journal of Medicine|July 14, 2016
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S Davids, Haesook T Kim, Pavan Bachireddy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2014
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiationEdward A Copelan, Belinda R Avalos, Kwang Woo Ahn, et al.
Blood Advances|November 7, 2018
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemiaSaurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor LymphomaAlex F Herrera, Scott J Rodig, Joo Y Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.
Blood Advances|October 2, 2020
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDSVikas Gupta, Soyoung Kim, Zhen-Huan Hu, et al.
Pageof 18